A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2001
10/25/2001	US20010034353 Administering a mixture of antibiotic, nonsteroid antiinflammatory drug and a quinolone compound
10/25/2001	US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001	US20010034339 For eyes, ears or noses
10/25/2001	US20010034329 Nucleic acids
10/25/2001	US20010034062 For engineering cells for delivery of antibodies to combat respiratory diseases, viral infection, asthma, allergy, and macular degeneration
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2407531A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001	CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/24/2001	EP1148128A1 Gene locus involved in regulating hair pigmentation, vestibular function and fertility
10/24/2001	EP1148054A1 Thyroid receptor ligands
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147771A1 Pharmaceutical formulation containing amoxycillin and clavulanate
10/24/2001	EP1147202A2 Plasminogen kringle 4 region fragments and methods of use
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1147113A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
10/24/2001	EP1147107A1 Novel angiogenesis inhibitors
10/24/2001	EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147084A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
10/24/2001	EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146877A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
10/24/2001	EP1146875A1 Myt1 kinase inhibitors
10/24/2001	EP1146870A1 Antioxidant compositions and methods for companion animals
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001	CN1318396A External-use medicine for treating purulent tympanitis
10/24/2001	CN1318388A Eye disease preventing oral liquid and its preparation
10/24/2001	CN1073443C Medicine for treatment of myopia
10/24/2001	CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist
10/24/2001	CN1073419C Compound eye drops for preventing and treating eye infection and its preparation
10/23/2001	US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma.
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307022 Def
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306586 Methods and compositions for the diagnosis and treatment of cataracts
10/23/2001	CA2236368C Sublingual and buccal administration of selegiline
10/23/2001	CA2222657C Intermediates in preparation of new phenylethanolaminomethyltetralins
10/23/2001	CA2087606C (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
10/23/2001	CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
10/18/2001	WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001	WO2001077085A1 Quinazoline compounds
10/18/2001	WO2001076694A1 Inhibitors of prenyl-protein transferase
10/18/2001	WO2001076590A2 Treatment for benign positional vertigo using antiepileptics
10/18/2001	WO2001076585A2 Use of thiamphenicol for the treatment of chlamydia pneumoniae infections
10/18/2001	WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031754 Method for treating ocular pain
10/18/2001	US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405476A1 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001	CA2404971A1 Human protein kinases and protein kinase-like enzymes
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403365A1 Quinazoline compounds

1 ... 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ... 531